Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts" report has been added to ResearchAndMarkets.com's offering.

The Biopsy Devices market is anticipated to grow at US$ 4.02 billion by 2033 from US$ 2.43 billion in 2024 at a CAGR of 5.75% during the period of 2025 to 2033. A few of the primary drivers of the market include the increasing need for personalized care, the increasing prevalence of cancer, and the need for minimally invasive treatments to enhance patient comfort and reduce recovery times.



Biopsy equipment are medical devices used to remove tissue samples from the body for the purposes of diagnosis. Biopsy equipment is very important in disease identification, especially cancer, since it enables doctors to examine cells in a laboratory environment. There are different types of biopsy equipment such as needle biopsy equipment, punch biopsy equipment, and surgical biopsy tools, each specific to a different medical condition or body area.

Needle biopsy machines, including fine-needle aspirators and core needle biopsy systems, can be utilized for non-invasive sampling, enabling physicians to obtain tissue with minimal effect on healthy tissue in the area. Punch biopsy equipment is frequently used for skin sampling, whereas surgical biopsy equipment can be required for deeper or more extensive tissue sampling.

Use of biopsy devices makes early diagnosis and correct detection possible, allowing for timely and suitable treatment strategies. Biopsy devices are becoming more accurate and less invasive as technology evolves, making them more comfortable for patients and enhancing the quality of care. Their role in contemporary medicine cannot be overemphasized since they offer critical information for guiding treatment and improving patient care.

Key Attributes:

Report AttributeDetailsNo. of Pages200Forecast Period2024 - 2033Estimated Market Value (USD) in 2024$2.43 BillionForecasted Market Value (USD) by 2033$4.02 BillionCompound Annual Growth Rate5.7%Regions CoveredGlobal

Revenue Analysis

Cardinal Health, IncHologic, Inc.Danaher CorporationBecton, Dickinson and CompanyBoston Scientific CorporationMedtronic plc.Olympus CorporationCONMED CorporationArgon Medical Devices, Inc.Cook Medical (Cook Group)INRAD, Inc.FUJIFILM Holdings CorporationStryker CorporationMerit Medical Systems, Inc.B. Braun Melsungen AG

Global Biopsy Devices Market

Historical TrendsForecast Analysis

Market Share Analysis - Global Biopsy Devices Industry

Company Analysis

Overview

Company History and MissionBusiness Model and OperationsWorkforce

Key Persons

Executive LeadershipOperational ManagementDivision LeadersBoard Composition

Recent Development & Strategies

Mergers & AcquisitionsPartnershipsInvestments

Sustainability Analysis

Renewable Energy AdoptionEnergy-Efficient InfrastructureUse of Sustainable Packaging MaterialsWater Usage and Conservation StrategiesWaste Management and Circular Economy Initiatives

Product Analysis

Product ProfileQuality StandardsProduct PipelineProduct Benchmarking

Strategic Assessment: SWOT Analysis

StrengthsWeaknessesOpportunitiesThreats

For more information about this report visit https://www.researchandmarkets.com/r/ajzd94

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

Biopsy Devices Market